Skip to content

HENRY SCHEIN

Active
Public limited companyfounded 1948active for 78 yearsLuchthavenlaan 20, 1800 Vilvoorde, BelgiumKBO/BCE: BE 0403.138.334
Summary

The computed 12-month bankruptcy probability of HENRY SCHEIN is 3.8% (moderate). The 2024 annual accounts show equity of €1.1m and a net result of -€1.0m. Equity is shrinking by about 21% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 13% of 6,068 sector peers (NACE 46, financial year 2024). The company has been active since 1948 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
4th oldest company in Vilvoorde, Wholesale and retail trade sector2 sites
Size
€30.7mturnover 2024
Staff
71.1 FTE
Equity
€1.1m
Loss
-€1.0m
Financial health
47 Fair Checked score 2024
Bankruptcy probabilitywithin 12 months
3.8%
Structure
Parent
Henry Schein Inc
Holdings
1
Accounts 6 days early3 of 24 deeds read
Why 47raises riskFigures for financial year 2024 (filed 23-07-2025)Liquidity: current ratio 1.17, cash €137,815, halvedEquity €1.1m (8.4% of total assets)Loss of €1.0m, the second in a row (financial year 2024)Show the evidence

Checked score

Score 2024
47 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 11% of its sector peers (NACE 46, medium-sized)
Financial strength · tick = 2023
Weak
Solvency 33-7
equity 8.4% of total assets
Liquidity 9-6
short-term debt 77.1% · cash 1.1%
Profitability 9-3
return on assets -7.8%
Bankruptcy probability, 12 months
3.8% Moderate
0%0.5%1.5%4%10%≥ 25%

About 4 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (745 companies, NACE 46, medium-sized)
Last 24 months 11-2024: 1.2% 12-2024: 1.2%● unchanged vs 11-2024 01-2025: 1.2%● unchanged vs 12-2024 02-2025: 1.2%● unchanged vs 01-2025lowest value 03-2025: 1.2%● unchanged vs 02-2025 04-2025: 1.2%● unchanged vs 03-2025 05-2025: 1.2%● unchanged vs 04-2025 06-2025: 1.2%● unchanged vs 05-2025 07-2025: 1.3%▲ +0.1 percentage points vs 06-2025 08-2025: 1.6%▲ +0.3 percentage points vs 07-2025 09-2025: 1.6%● unchanged vs 08-2025 10-2025: 1.6%● unchanged vs 09-2025 11-2025: 1.6%● unchanged vs 10-2025 12-2025: 1.6%● unchanged vs 11-2025 01-2026: 1.6%● unchanged vs 12-2025 02-2026: 1.6%● unchanged vs 01-2026 03-2026: 1.6%● unchanged vs 02-2026 04-2026: 1.6%● unchanged vs 03-2026 05-2026: 1.6%● unchanged vs 04-2026 06-2026: 1.6%● unchanged vs 05-2026 07-2026: 1.8%▲ +0.2 percentage points vs 06-2026 08-2026: 2.3%▲ +0.5 percentage points vs 07-2026 09-2026: 2.6%▲ +0.3 percentage points vs 08-2026 10-2026: 3.8%▲ +1.2 percentage points vs 09-2026highest value
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.17, compared with 1.26 in 2023, below the usual 1.5; short-term debt: 77.1% and cash: 1.1% of total assets), and 91.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 13% on solvency, 10% on liquidity, 5% on profitability and 16% on growth.

The bankruptcy probability was computed on 16-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
raises riskneutral
raises risk · Figures for financial year 2024 (filed 23-07-2025)
NBB · annual accounts
raises risk · Liquidity: current ratio 1.17, cash €137,815, halved
NBB · annual accounts
raises risk · Equity €1.1m (8.4% of total assets)
NBB · annual accounts
raises risk · Loss of €1.0m, the second in a row (financial year 2024)
NBB · annual accounts
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024
Net result per financial year
18192021222324
2018 to 2024 · latest year -€1.0m
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 6068 sector peers (2024).
NBB · sector comparison
Position among 6068 sector peers
Solvency
better than 13%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 28-12-2024 was due by 28-07-2025 and was filed on 22-07-2025, 6 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2024
6 days early
2023
39 days early
2022
41 days early
2021
39 days early
2020
35 days early
2019
35 days early
2018
33 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 33 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Resignation: Daniel Isidoro do Nascimento (director)Appointments: Joost Bakker (director) and…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Reappointment: Balder Cornelis Willem Jan (director)Permanent representative: Sam Vander Vennet

Key points

  • Risk: 5 loss-making years in a rowloss financial year 2024 -€1.0m View
  • Caution: Among the weakest 5% on net resultsector median €93,918 · 6,079 companies -€1.0m View
  • Caution: Equity fell in 2024from €2.1m to €1.1m ▼ 48.2% View
  • Positive: Filed on time since financial year 2017accounts within the deadline every year 8 years View
  • Controlled by Henry Schein Incthe company in turn controls 1 companies parent View
  • Active since 1948founded 01-01-1948 78 years View

By topic

Financials

Financial year
2024
Turnover
€30.7m
Loss
-€1.0m
Solvency
8.4%
Turnover▼ 4.2%
Net result
20182024
Go to Financials

Timeline

Events
53
Since
1978
  1. 06-09-2024Reappointment: BDO Bedrijfsrevisoren BV (statutory auditor)
  2. 21-06-2024Annual accounts filed
  3. 20-06-2023Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
01-01-1948
Year ends
28-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.